Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, et al. Annual report to the nation on the status of cancer, part I: National Cancer Statistics. Cancer. 2020;126(10):2225–2249.
   PubMed Web of Science ®Google Scholar
• Buckup M, Rice MA, Hsu E-C, Garcia-Marques F, Liu S, Aslan M, Bermudez A, Huang J, Pitteri SJ, Stoyanova T. Plectin is a regulator of prostate cancer growth and metastasis. Oncogene. 2021;40(3):663–676.
   PubMed Web of Science ®Google Scholar
• Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N. Obesity, inflammation, and prostate cancer. J Clin Med. 2019;8(2):201.
   PubMed Web of Science ®Google Scholar
• Hennrich U, Eder M. [177Lu] Lu-PSMA-617 (PluvictoTM): the first FDA-approved radiotherapeutical for treatment of prostate cancer. Pharmaceuticals. 2022;15(10):1292.
   Web of Science ®Google Scholar
• Fallah J, Agrawal S, Gittleman H, Fiero MH, Subramaniam S, John C, Chen W, Ricks TK, Niu G, Fotenos A, et al. FDA approval summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 2023;29(9):1651–1657.
   PubMedGoogle Scholar
• Chen Y, Zhou Q, Hankey W, Fang X, Yuan F. Second generation androgen receptor antagonists and challenges in prostate cancer treatment. Cell Death Dis. 2022;13(7):632.
   PubMed Web of Science ®Google Scholar
• Ma C-C, Liu Z-P. Design and synthesis of coumarin derivatives as novel PI3K inhibitors. Anticancer Agents Med Chem. 2017;17(3):395–403.
   PubMed Web of Science ®Google Scholar
• Liu X, Xu Y, Zhou Q, Chen M, Zhang Y, Liang H, Zhao J, Zhong W, Wang M. PI3K in cancer: its structure, activation modes and role in shaping tumor microenvironment. Future Oncol. 2018;14(7):665–674.
   PubMed Web of Science ®Google Scholar
• Noser AA, Shehadi IA, Abdelmonsef AH, Salem MM. Newly synthesized pyrazolinone chalcones as anticancer agents via inhibiting the PI3K/Akt/ERK1/2 signaling pathway. ACS Omega. 2022;7(29):25265–25277.
   PubMedGoogle Scholar
• Wu Y, Xu J, Liu Y, Zeng Y, Wu G. A review on anti-tumor mechanisms of coumarins. Front Oncol. 2020;10:592853.
   PubMed Web of Science ®Google Scholar
• Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, Peterson TR, Choi Y, Gray NS, Yaffe MB, et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science. 2011;332(6035):1317–1322.
   PubMed Web of Science ®Google Scholar
• Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, Rostamzadeh D. mTOR-mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol. 2021;12:774103.
   PubMed Web of Science ®Google Scholar
• Makhov PB, Golovine K, Kutikov A, Teper E, Canter DJ, Simhan J, Uzzo RG, Kolenko VM. Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells. Mol Cancer Ther. 2012;11(7):1510–1517.
   PubMed Web of Science ®Google Scholar
• Yasumizu Y, Miyajima A, Kosaka T, Miyazaki Y, Kikuchi E, Oya M. Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer. J Urol. 2014;191(1):227–234.
   PubMed Web of Science ®Google Scholar
• Croisy-Delcey M, Croisy A, Mousset S, Letourneur M, Bisagni E, Jacquemin-Sablon A, Pierre J. Genistein analogues: effects on epidermal growth factor receptor tyrosine kinase and on stress-activated pathways. Biomed Pharmacother. 1997;51(6–7):286–294.
   PubMed Web of Science ®Google Scholar
• Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, et al. HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone. Cancer Res. 2017;77(1):74–85.
   PubMed Web of Science ®Google Scholar
• Tseng J-C, Wang B-J, Wang Y-P, Kuo Y-Y, Chen J-K, Hour T-C, Kuo L-K, Hsiao P-J, Yeh C-C, Kao C-L, et al. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells. Phytomedicine. 2023;116:154860.
   PubMed Web of Science ®Google Scholar
• Wang T, Peng T, Wen X, Wang G, Sun Y, Liu S, Zhang S, Wang L. Design, synthesis and preliminary biological evaluation of benzylsulfone coumarin derivatives as anti-cancer agents. Molecules. 2019;24(22):4034.
   PubMed Web of Science ®Google Scholar
• Shen P, Wang H-G, Li M-M, Ma Q-Y, Zhou C-W, Pan F, Xie R. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells. Biomed Pharmacother. 2017;92:78–85.
   PubMed Web of Science ®Google Scholar
• García-Vilas JA, Quesada AR, Medina MÁ. 4-Methylumbelliferone inhibits angiogenesis in vitro and in vivo. J Agric Food Chem. 2013;61(17):4063–4071.
   PubMed Web of Science ®Google Scholar
• Kishk SM, Eltamany EE, Nafie MS, Khinkar RM, Hareeri RH, Elhady SS, Yassen AS. Design and synthesis of coumarin derivatives as cytotoxic agents through PI3K/AKT signaling pathway inhibition in HL60 and HepG2 cancer cells. Molecules. 2022;27(19):6709.
   PubMed Web of Science ®Google Scholar
• Turkekul K, Colpan RD, Baykul T, Ozdemir MD, Erdogan S. Esculetin inhibits the survival of human prostate cancer cells by inducing apoptosis and arresting the cell cycle. J Cancer Prev. 2018;23(1):10–17.
   PubMedGoogle Scholar
• Jeon YJ, Cho JH, Lee SY, Choi YH, Park H, Jung S, Shim JH, Chae JI. Esculetin induces apoptosis through EGFR/PI3K/Akt signaling pathway and nucleophosmin relocalization. J Cell Biochem. 2016;117(5):1210–1221.
   PubMed Web of Science ®Google Scholar
• Ghany LMA, El-Dydamony NM, Helwa AA, Abdelraouf SM, Abdelnaby RM. Coumarin-acetohydrazide derivatives as novel antiproliferative agents via VEGFR-2/AKT axis inhibition and apoptosis triggering. New J Chem. 2022;46(36):17394–17409.
   Web of Science ®Google Scholar
• Sairam KV, Gurupadayya B, Vishwanathan BI, Chandan R, Nagesha DK. Cytotoxicity studies of coumarin analogs: design, synthesis and biological activity. RSC Adv. 2016;6(101):98816–98828.
   Web of Science ®Google Scholar
• Takla FN, Bayoumi WA, El-Messery SM, Nasr MN. Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study. Sci Rep. 2023;13(1):13370.
   PubMed Web of Science ®Google Scholar
• Eliwa EM, Frese M, Halawa AH, Soltan MM, Ponomareva LV, Thorson JS, Shaaban KA, Shaaban M, El-Agrody AM, Sewald N. Metal-free domino amination-Knoevenagel condensation approach to access new coumarins as potent nanomolar inhibitors of VEGFR-2 and EGFR. Green Chem Lett Rev. 2021;14(4):578–599.
   PubMed Web of Science ®Google Scholar
• BioRender; 2023. Available from: https://app.biorender.com/biorender-templates
   Google Scholar
• Shawish I, Barakat A, Aldalbahi A, Malebari AM, Nafie MS, Bekhit AA, Albohy A, Khan A, Ul-Haq Z, Haukka M, et al. Synthesis and antiproliferative activity of a new series of mono- and bis(dimethylpyrazolyl)-s-triazine derivatives targeting EGFR/PI3K/AKT/mTOR signaling cascades. ACS Omega. 2022;7(28):24858–24870.
   PubMed Web of Science ®Google Scholar
• Tian Q, Wang G, Ma X, Shen Q, Ding M, Yang X, Luo X, Li R, Wang Z, Wang X, et al. Riboflavin integrates cellular energetics and cell cycle to regulate maize seed development. Plant Biotechnol J. 2022;20(8):1487–1501.
   PubMed Web of Science ®Google Scholar
• Kattan SW, Nafie MS, Elmgeed GA, Alelwani W, Badar M, Tantawy MA. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: implication of PI3K/AKT/mTOR pathway. J Steroid Biochem Mol Biol. 2020;198:105604.
   PubMed Web of Science ®Google Scholar
• Hussar P. Apoptosis regulators bcl-2 and caspase-3. Encyclopedia. 2022;2(4):1624–1636.
   Google Scholar
• Lossi L. The concept of intrinsic versus extrinsic apoptosis. Biochem J. 2022;479(3):357–384.
   PubMed Web of Science ®Google Scholar
• MOE. Montreal, Canada: Molecular Operating Environment (MOE) CCGU; 2023.
   Google Scholar
• Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem. 2002;277(48):46265–46272.
   PubMed Web of Science ®Google Scholar
• Furet P, Guagnano V, Fairhurst RA, Imbach-Weese P, Bruce I, Knapp M, Fritsch C, Blasco F, Blanz J, Aichholz R, et al. Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett. 2013;23(13):3741–3748.
   PubMed Web of Science ®Google Scholar
• El-Ansary SL, Hussein MM, Rahman DEA, Ghany LMA. Synthesis, docking and in vitro anticancer evaluation of some new benzopyrone derivatives. Bioorg Chem. 2014;53:50–66.
   PubMed Web of Science ®Google Scholar
• Canter FW, Curd FH, Robertson A. CLXVI.—Hydroxy-carbonyl compounds. Part III. The preparation of coumarins and 1: 4-benzopyrones from phloroglucinol and resorcinol. J Chem Soc (Resumed). 1931;1255–1265.
   Google Scholar
• Yu X, Wen Y, Liang C-G, Liu J, Ding Y-B, Zhang W-H. Design, synthesis and antifungal activity of psoralen derivatives. Molecules. 2017;22(10):1672.
   PubMed Web of Science ®Google Scholar
• Shilin S, Garazd M, Khilya V. Synthesis of dipeptide derivatives of 3,4-substituted 7-hydroxycoumarins. Chem Nat Compd. 2008;44(3):301–305.
   Web of Science ®Google Scholar
• Timonen J, Vuolteenaho K, Leppänen T, Nieminen R, Moilanen E, Aulaskari P, Jänis J. 7‐(2‐Oxoalkoxy) coumarins: synthesis and anti‐inflammatory activity of a series of substituted coumarins. J Heterocycl Chem. 2015;52(5):1286–1295.
   Web of Science ®Google Scholar
• El-Ansary SL, Rahman DEA, Ghany LMA. Synthesis and anticancer evaluation of some new 3-benzyl-4,8-dimethylbenzopyrone derivatives. Open Med Chem J. 2017;11(1):81–91.
   PubMedGoogle Scholar
• Van de Loosdrecht A, Beelen R, Ossenkoppele G, Broekhoven M, Langenhuijsen M. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods. 1994;174(1–2):311–320.
   PubMed Web of Science ®Google Scholar
• Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988;48(3):589–601.
   PubMed Web of Science ®Google Scholar
• Kvastad L, Werne Solnestam B, Johansson E, Nygren AO, Laddach N, Sahlén P, Vickovic S, Bendigtsen SC, Aaserud M, Floer L, et al. Single cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring. Sci Rep. 2015;5(1):16519.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Abo-Ashour MF, Ibrahim HS, Al-Ansary GH, Ghabbour HA, Elaasser MM, Ahmed HY, Safwat NA. Novel [(3-indolylmethylene) hydrazono] indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation. J Enzyme Inhib Med Chem. 2018;33(1):686–700.
   PubMed Web of Science ®Google Scholar
• Alkhaldi AAM, Al-Sanea MM, Nocentini A, Eldehna WM, Elsayed ZM, Bonardi A, Abo-Ashour MF, El-Damasy AK, Abdel-Maksoud MS, Al-Warhi T, et al. 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: design, synthesis, biological and molecular modeling studies. Eur J Med Chem. 2020;207:112745.
   PubMed Web of Science ®Google Scholar
• El-Naggar M, Eldehna WM, Almahli H, Elgez A, Fares M, Elaasser MM, Abdel-Aziz HA. Novel thiazolidinone/thiazolo[3,2-a]benzimidazolone–isatin conjugates as apoptotic anti-proliferative agents towards breast cancer: one-pot synthesis and in vitro biological evaluation. Molecules. 2018;23(6):1420.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Nocentini A, Elsayed ZM, Al-Warhi T, Aljaeed N, Alotaibi OJ, Al-Sanea MM, Abdel-Aziz HA, Supuran CT. Benzofuran-based carboxylic acids as carbonic anhydrase inhibitors and antiproliferative agents against breast cancer. ACS Med Chem Lett. 2020;11(5):1022–1027.
   PubMed Web of Science ®Google Scholar
• Sanduja M, Gupta J, Rawat R, Singh U, Verma SM. Designing, molecular docking, and dynamics simulations studies of 1,2,3-triazole clamped uracil–coumarin hybrids against EGFR tyrosine kinase. J Appl Pharm Sci. 2020;10(3):1–11.
   Google Scholar
• Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inf Model. 2009;49(2):444–460.
   PubMed Web of Science ®Google Scholar